₹ 1,881.60
62.60 (3.44%)
NSE
B
Beta Drugs
₹ 1,881.60
NSE
Beta Drugs EPS Summary (consolidated)
The latest quarterly EPS of Beta Drugs as of Q2 Sep 2026 stands at ₹16.59. This is a 12.25% growth quarter on quarter and 37.11% growth same quarter last year. For the FY2026 the EPS of Beta Drugs stands at ₹40.92. This is a 2.62% fall compared with FY2025.
Beta Drugs EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

